Medichem's workforce is expected to increase by 10% in the coming months, Minister for Energy, Enterprise and Sustainable Development Miriam Dalli said today.

This is possible with the latest developments in Medichem's product testing and manufacturing, she added.

Thanks to Medichem and Malta's dynamic and entrepreneurial proven track record, Dalli said it will positively change the Maltese pharmaceutical sector.

Elisabeth Stampa, CEO of Medichem group, said that it is an honour for the company to continue growing and developing in Malta. She said the company has found its total support from the government and Malta Enterprise.

Stampa said that Medichem, which has been investing in Malta since 2004, will be investing a total of €6 million to increase the volume of pharmaceutical goods produced. She added that €3 million were invested in the retraining and health and safety of the workforce.

Chief Executive Malta Enterprise Officer Kurt Farrugia said that the Malta Enterprise is very proud of Medichem and the fruitful developments brought to the pharmaceutical sector in Malta. He added that Malta Enterprise looks forward to supporting Malta in its upcoming ventures, which will bring new and competitive markets opportunities for this sector in Malta.

In addressing the media after the conference Dalli said through the covid wage supplement extension, the government had wanted to continue to assist the private sector during the pandemic. Adding that as the Covid situation is a constantly developing one, the government and the Malta Enterprise have sought to do ongoing meetings with several businesses and stakeholders, where it resulted that an extension in the wage supplement until January will be beneficial.

In reaching such a decision, Dalli said that the government ensures that it protects business and their future growth.